Investors

Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and...
More

Stock Quote
XTNT (Common Stock)
Price$1.14
Change (%) - 0.01 (0.87%)
Volume5,985
Data as of 09/28/16 12:50 p.m. ET
Refresh quote

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: XTNT.K.  Currently trading at $1.14 with a 52 week high of $3.75 and a 52 week low of $0.93.
Recent News
DateTitle 
08/29/16Xtant Medical Files S-1 Registration Statement for Rights Offering to Shareholders
BELGRADE, Mont., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced it filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a rights offering to its existing stockholders. Under the proposed rights offering, the Company would distribute non-transferable subscription rights to pur... 
08/19/16Xtant Medical Receives Non Compliance Notice from NYSE MKT
BELGRADE, Mont., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that the NYSE MKT LLC (the "Exchange") notified the Company that it is not in compliance with Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the Company Guide due to negative stockholders equity of approximately $496,000 as of June 30, 2016 and net losses in ... 
08/16/16Xtant Medical Expands AR Credit Facility with Silicon Valley Bank
Expanded credit facility to provide additional liquidity for future growth BELGRADE, Mont., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced the expansion of the accounts receivable revolver credit facility with Silicon Valley Bank to provide an additional $5 million in funds, making the total credit facility available, $11 mill... 
08/01/16Xtant™ Medical Reports Second Quarter 2016 Results
*See footnote about the use of pro forma financial information Second Quarter 2016 Highlights: Core recurring revenue (excluding OEM and other revenue) increased 5.6% to $20.9 million compared to core pro forma recurring revenue of $19.8 million in second quarter 2015  Gross profit increased to $14.7 million, compared to pro forma second quarter 2015 gross profit of $14.0 million  Gross margins improved to 68.5% compared to 64.9% for the second quarter of 2015  The Company... 
More

Upcoming Events
There are currently no events scheduled.
More

Receive E-mail Alerts
Sign up to receive e-mail alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your e-mail address and click Submit.